Cargando…
The effectiveness and value of tezepelumab for severe asthma: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373025/ https://www.ncbi.nlm.nih.gov/pubmed/35471071 http://dx.doi.org/10.18553/jmcp.2022.28.5.577 |
| _version_ | 1785078477059260416 |
|---|---|
| author | Rind, David M McQueen, R. Brett Herron-Smith, Serina Herce-Hagiwara, Belén Gutierrez, Eric Campbell, Jon D Fluetsch, Noemi Pearson, Steven D |
| author_facet | Rind, David M McQueen, R. Brett Herron-Smith, Serina Herce-Hagiwara, Belén Gutierrez, Eric Campbell, Jon D Fluetsch, Noemi Pearson, Steven D |
| author_sort | Rind, David M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10373025 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Academy of Managed Care Pharmacy |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103730252023-07-31 The effectiveness and value of tezepelumab for severe asthma: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum Rind, David M McQueen, R. Brett Herron-Smith, Serina Herce-Hagiwara, Belén Gutierrez, Eric Campbell, Jon D Fluetsch, Noemi Pearson, Steven D J Manag Care Spec Pharm Perspectives on Value Academy of Managed Care Pharmacy 2022-05 /pmc/articles/PMC10373025/ /pubmed/35471071 http://dx.doi.org/10.18553/jmcp.2022.28.5.577 Text en Copyright © 2022, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Perspectives on Value Rind, David M McQueen, R. Brett Herron-Smith, Serina Herce-Hagiwara, Belén Gutierrez, Eric Campbell, Jon D Fluetsch, Noemi Pearson, Steven D The effectiveness and value of tezepelumab for severe asthma: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
| title | The effectiveness and value of tezepelumab for severe asthma: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
| title_full | The effectiveness and value of tezepelumab for severe asthma: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
| title_fullStr | The effectiveness and value of tezepelumab for severe asthma: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
| title_full_unstemmed | The effectiveness and value of tezepelumab for severe asthma: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
| title_short | The effectiveness and value of tezepelumab for severe asthma: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
| title_sort | effectiveness and value of tezepelumab for severe asthma: a summary from the institute for clinical and economic review’s california technology assessment forum |
| topic | Perspectives on Value |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373025/ https://www.ncbi.nlm.nih.gov/pubmed/35471071 http://dx.doi.org/10.18553/jmcp.2022.28.5.577 |
| work_keys_str_mv | AT rinddavidm theeffectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT mcqueenrbrett theeffectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT herronsmithserina theeffectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT hercehagiwarabelen theeffectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT gutierrezeric theeffectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT campbelljond theeffectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT fluetschnoemi theeffectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT pearsonstevend theeffectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT rinddavidm effectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT mcqueenrbrett effectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT herronsmithserina effectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT hercehagiwarabelen effectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT gutierrezeric effectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT campbelljond effectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT fluetschnoemi effectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT pearsonstevend effectivenessandvalueoftezepelumabforsevereasthmaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum |